Anticoagulant Options for Atrial Fibrillation
Evidence-Based Hierarchy of Options
- The American College of Cardiology strongly recommends against antiplatelet therapy alone (including aspirin monotherapy) for stroke prevention in atrial fibrillation patients, regardless of stroke risk 2
- Aspirin offers minimal protection with only 19% stroke reduction (95% CI 2% to 34%) in atrial fibrillation patients 1
- Aspirin is more effective at preventing nondisabling strokes rather than disabling cardioembolic strokes, which are the most dangerous type in atrial fibrillation 1
- Aspirin may have slightly better efficacy in patients with hypertension or diabetes 1
- Aspirin plus clopidogrel provides 28% relative risk reduction compared to aspirin alone, but comes with 57% relative increase in major bleeding 3, 4
- This combination is inferior to warfarin for stroke prevention (42% relative risk reduction favoring warfarin) with similar major bleeding rates 3, 4, 5